Ranferi Ocaña-Guzman (Ranferi Ocaña-Guzmán)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 10

Top Venues

Journal of immunology research

Immunity, inflammation and disease

Cancers

Pharmaceuticals (Basel, Switzerland)

Instituto Nacional de Enfermedades Respiratorias

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Instituto Nacional de Enfermedades Respiratorias

Mexico

Medical-Science Researcher

Publications

Ivette Buendia-Roldan, Karen Martínez-Espinosa, Maria-Jose Aguirre, Hiram Aguilar-Duran, Alexia Palma-Lopez, Yadira Palacios, Andy Ruiz, Lucero A Ramón-Luing, Ranferi Ocaña-Guzman, Gloria Pérez-Rubio, Ramcés Falfán-Valencia, Moisés Selman, Leslie Chavez Galan
Persistence of lung structural and functional alterations at one year post-COVID-19 is associated with increased serum PD-L2 levels and altered CD4/CD8 ratio. Immunity, inflammation and disease 12 (7) (2024)
Ivette Buendia-Roldan, Karen Martínez-Espinosa, Maria-Jose Aguirre, Hiram Aguilar-Duran, Alexia Palma-Lopez, Yadira Palacios, Andy Ruiz, Lucero A Ramón-Luing, Ranferi Ocaña-Guzman, Gloria Pérez-Rubio, Ramcés Falfán-Valencia, Moisés Selman, Leslie Chavez Galan
Persistence of lung structural and functional alterations at one year post-COVID-19 is associated with increased serum PD-L2 levels and altered CD4/CD8 ratio. Immunity, inflammation and disease 12 (7) (2024)
Ivette Buendia-Roldan, Karen Martínez-Espinosa, Maria-Jose Aguirre, Hiram Aguilar-Duran, Alexia Palma-Lopez, Yadira Palacios, Andy Ruiz, Lucero A Ramón-Luing, Ranferi Ocaña-Guzman, Gloria Pérez-Rubio, Ramcés Falfán-Valencia, Moisés Selman, Leslie Chavez Galan
Persistence of lung structural and functional alterations at one year post-COVID-19 is associated with increased serum PD-L2 levels and altered CD4/CD8 ratio. Immunity, inflammation and disease 12 (7) (2024)
Ranferi Ocaña-Guzman, Lucero A Ramón-Luing, Luis A Vazquez-Bolaños, Michelle Rodríguez-Alvarado, Fausi Bulhusen-Rodriguez, Alonso Torres-Hatem, Karen Gonzalez-Torres, Mariana Citlalli de Alba-Alvarado, Isabel Sada-Ovalle
Tim-3 Is Differentially Expressed during Cell Activation and Interacts with the LSP-1 Protein in Human Macrophages. Journal of immunology research 2023 (2023)
Ranferi Ocaña-Guzman, Diego Osorio-Pérez, Leslie Chavez Galan
Opportunistic Infections and Immune-Related Adverse Events Associated with Administering Immune Checkpoint Inhibitors: A Narrative Review. Pharmaceuticals (Basel, Switzerland) 16 (8) (2023)
Julio Flores-González, Lucero A Ramón-Luing, Ranferi Ocaña-Guzman, Ivette Buendia-Roldan, Beda Islas-Muñoz, Patricia Volkow-Fernández, Leslie Chavez Galan
Valganciclovir as Add-On Therapy Modifies the Frequency of NK and NKT Cell Subpopulations in Disseminated Kaposi Sarcoma Patients. Cancers 14 (2) (2022)
Ranferi Ocaña-Guzman, Lucero A Ramón-Luing, Michelle Rodríguez-Alvarado, Timo-Daniel Voss, Tina Fuchs, Leslie Chavez Galan
Murine RAW Macrophages Are a Suitable Model to Study the CD3 Signaling in Myeloid Cells. Cells 11 (10) (2022)
Ranferi Ocaña-Guzman, Norma A Téllez-Navarrete, Lucero A Ramón-Luing, Iliana Herrera, Marlon De Ita, José-Luis Carrillo-Alduenda, José Alberto Choreño-Parra, Karen Medina-Quero, Joaquín Zúñiga, Leslie Chavez Galan
Leukocytes from Patients with Drug-Sensitive and Multidrug-Resistant Tuberculosis Exhibit Distinctive Profiles of Chemokine Receptor Expression and Migration Capacity. Journal of immunology research 2021 (2021)
Carlos Machahua, Ivette Buendia-Roldan, Ranferi Ocaña-Guzman, María Molina-Molina, Annie Pardo, Leslie Chavez Galan, Moisés Selman
CD4+T cells in ageing-associated interstitial lung abnormalities show evidence of pro-inflammatory phenotypic and functional profile. Thorax 76 (2) (2020)
Ranferi Ocaña-Guzman, Luis A Vazquez-Bolaños, Isabel Sada-Ovalle
Receptors That Inhibit Macrophage Activation: Mechanisms and Signals of Regulation and Tolerance. Journal of immunology research 2018 (2018)

Ranferi Ocaña-Guzman.css-eqlu8i{font-size:small;padding-left:4px;} (Ranferi Ocaña-Guzmán)

Publication Activity (10 Years)

Top Topics

Top Venues

Ranferi Ocaña-Guzman (Ranferi Ocaña-Guzmán)